U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07314905) titled 'Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)' on Oct. 01, 2025.
Brief Summary: TreatResp is a double-blind, individually randomized, multi-centre adaptive platform trial. TreatResp aims to establish an adaptive platform trial aimed at evaluating the clinical- and cost-effectiveness, practical challenges, and outcomes of therapeutics for respiratory pathogens in non-hospitalized patients. Participants will be randomized to receive usual care (i.e., supportive care and symptom relief) or a study therapeutic, which will be determined by the TreatResp Therapeutics Committee. The prima...